Peptide Blockers of PD-1-PD-L1 Interaction Reinvigorate PD-1-Suppressed T Cells and Curb Tumor Growth in Mice
Cells · 15.07.2024 · 13 (14) · 1193
DOI: 10.3390/cells13141193 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cells, online erschienen am 15.07.2024. Verfasst von Shanshan Jenny Zhong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada. Hauptthemen laut MEDLINE: Programmed Cell Death 1 Receptor, B7-H1 Antigen, Peptides, T-Lymphocytes. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 35 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Canadian Institute of Health Research, Natural Sciences and Engineering Research Council of Canada.
Abstract (Originalsprache)
The programmed cell death protein 1 (PD-1) plays a critical role in cancer immune evasion. Blocking the PD-1-PD-L1 interaction by monoclonal antibodies has shown remarkable clinical efficacy in treating certain types of cancer. However, antibodies are costly to produce, and antibody-based therapies can cause immune-related adverse events. To address the limitations associated with current PD-1/PD-L1 blockade immunotherapy, we aimed to develop peptide-based inhibitors of the PD-1/PD-L1 interaction as an alternative means to PD-1/PD-L1 blockade antibodies for anti-cancer immunotherapy. Through the functional screening of peptide arrays encompassing the ectodomains of PD-1 and PD-L1, followed by the optimization of the hit peptides for solubility and stability, we have identified a 16-mer peptide, named mL7N, with a remarkable efficacy in blocking the PD-1/PD-L1 interaction both in vitro and in vivo. The mL7N peptide effectively rejuvenated PD-1-suppressed T cells in multiple cellular systems designed to recapitulate the PD-1/PD-L1 interaction in the context of T-cell receptor signaling. Furthermore, PA-mL7N, a chimera of the mL7N peptide coupled to albumin-binding palmitic acid (PA), significantly promoted breast cancer cell killing by peripheral blood mononuclear cells ex vivo and significantly curbed tumor growth in a syngeneic mouse model of breast cancer. Our work raises the prospect that mL7N may serve as a prototype for the development of a new line of peptide-based immunomodulators targeting the PD-1/PD-L1 immune checkpoint with potential applications in cancer treatment.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Biochemistry, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada.
- Department of Microbiology and Immunology, Schulich School of Medicine and Dentistry, Western University, London, ON N6A 5C1, Canada.
- School of Health and Life Sciences, Health and Rehabilitation University, 369 Dengyun Rd, Qingdao 266071, China.
ORCID-Profile: Shanshan Jenny Zhong, Owen Hovey, Sung Kim
Förderung
- Canadian Institute of Health Research
- Natural Sciences and Engineering Research Council of Canada
Zitieren
APA
Zhong, S. J., Liu, X., Kaneko, T., Feng, Y., Hovey, O., Yang, K., Ezra, S., Ha, S. D., Kim, S., McCormick, J. K., Liu, H., & Li, S. S. (2024). Peptide Blockers of PD-1-PD-L1 Interaction Reinvigorate PD-1-Suppressed T Cells and Curb Tumor Growth in Mice. Cells, 13(14), 1193. https://doi.org/10.3390/cells13141193
Vancouver
Zhong SJ, Liu X, Kaneko T, Feng Y, Hovey O, Yang K, et al. Peptide Blockers of PD-1-PD-L1 Interaction Reinvigorate PD-1-Suppressed T Cells and Curb Tumor Growth in Mice. Cells. 2024;13(14):1193. doi:10.3390/cells13141193
BibTeX
@article{Zhong2024,
author = {Zhong, Shanshan Jenny and Liu, Xiaoling and Kaneko, Tomonori and Feng, Yan and Hovey, Owen and Yang, Kyle and Ezra, Sally and Ha, Soon-Duck and Kim, Sung and McCormick, John K and Liu, Huadong and Li, Shawn Shun-Cheng},
title = {Peptide Blockers of PD-1-PD-L1 Interaction Reinvigorate PD-1-Suppressed T Cells and Curb Tumor Growth in Mice},
journal = {Cells},
year = {2024},
volume = {13},
number = {14},
pages = {1193},
doi = {10.3390/cells13141193}
}
EUVIMED